PFM Health Sciences’s iShares China Large-Cap ETF FXI Stock Holding History

PFM Health Sciences’s Portfolio FXI Stock Details FXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-141,122	Closed	-$3.4M	–	85
2024 Q1	$3.4M	Buy	+141,122	New	+$3.25M	0.16%	76
2023 Q3	–	Sell	-398,720	Closed	-$10.8M	–	78
2023 Q2	$10.8M	Buy	+398,720	New	+$11.2M	0.42%	58

Other funds holding FXI

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PFM Health Sciences's FXI Position: Q2 2024 in Review

PFM Health Sciences sold out of iShares China Large-Cap ETF (FXI) in Q2 2024, closing a stake of 141,122 shares — an estimated $3.4M sold.

PFM Health Sciences first reported a position in FXI in Q2 2023 and held it in 2 quarters. The position peaked at $10.8M in Q2 2023. 254 funds tracked by Wall St. Rank hold FXI as of Q2 2024.

PFM Health Sciences reported no remaining iShares China Large-Cap ETF position as of Q2 2024 after selling out during the quarter.
PFM Health Sciences sold 141,122 iShares China Large-Cap ETF shares in Q2 2024, an estimated $3.4M.
PFM Health Sciences first reported a position in iShares China Large-Cap ETF in Q2 2023 and held it in 2 quarters.
PFM Health Sciences's iShares China Large-Cap ETF position peaked at $10.8M in Q2 2023.
254 funds tracked by Wall St. Rank held iShares China Large-Cap ETF as of Q2 2024.

Based on PFM Health Sciences's 13F filing for Q2 2024, filed 14 Aug 2024.